Tenax Therapeutics, Inc. ( TENX) - Stock Earnings
TENX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
TENX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -15.5 million USD | — USD |
| 2026Q1 | -15.7 million USD | — USD |
| 2026Q2 | -17.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TENX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.7 million USD | — USD |
| 2024 | -17.6 million USD | — USD |
| 2025 | -52.6 million USD | — USD |
| 2026 Est. | — | — |
TENX
Price: $1.52
52 week price:
Earnings Per Share: -1.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 57000
Ebitda: -44.8 millionMarket Capitalization: 52.5 million